A preliminary survey of paranormal experiences with psychoactive drugs

Journal of Parapsychology

Volumn 69, Issue 2, 2005, Pages 305-327

  Luke, David P ^a   Kittenis, Marios ^b  

^a UNIVERSITY OF NORTHAMPTON   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34248551074     PISSN: 00223387     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. ATKINSON, J. (2004). Does the Salvia multiverse have intent? [Audio CDROM]. Paper presented at the international conference Exploring Consciousness: With What Intent? Bath Spa University, UK.
2. BLACKMORE, S. J. (1982). Have you ever had an OBE: The wording of the question. Journal of the Society for Psychical Research, 51, 292-302.
3. BLACKMORE, S. J. (1984). A postal survey of OBEs and other experiences. Journal of the Society for Psychical Research, 52, 225-244.
4. BLACKMORE, S. J. (1992). Beyond the body: An investigation of out-of-the-body experiences. Chicago, IL: Academy Chicago.
5. BLACKMORE, S.J., & HARRIS, J. (1983). OBEs and perceptual distortions in schizophrenic patients and students [Abstract]. In W. G. Roll, J. Beloff, & R. A. White (Eds.), Research in parapsychology 1982 (pp. 232-234). Metuchen, NJ: Scarecrow Press.
6. DEGRACIA, D. J. (1995). Do psychedelic drugs mimic awakened kundalini? Hallucinogen survey results. Retrieved October 27, 2004, from http://www.csp.org/practices/entheogens/docs/kundalini_ survey.html.
7. DEPARTMENT OF HEALTH (2004). The score: Facts about drugs. London: Department of Health Publications.
8. DOBKIN DE RIOS, M. (1972). Visionary vine: Hallucinogenic healing in the Peruvian Amazon. Prospect Heights, IL: Waveland Press.
9. EISNER, B. (1989). Ecstasy: The MDMA story. Berkeley, CA: Ronin Publishing.
10. GALLAGHER, C., KUMAR, V. K., & PEKALA, R. J. (1994). The anomalous experiences inventory: Reliability and validity. Journal of Parapsychology, 58, 402-428.
11. GRINSPOON, L., & BAKALAR, J. B. (1998). Psychedelic drugs reconsidered (2nd ed.). New York: The Lindesmith Centre.
12. GROF, S. (1990). Survival after death: Observations from modern consciousness research. In G. Doore (Ed.), What survives? Contemporary explanations of life after death (pp. 22-33). Los Angeles: Tarcher.
13. HARVEY, G. (2005). An animist manifesto. Strange Attractor Journal, 2, 124-129.
14. HEWSON, C. (2003). Conducting research on the internet. The Psychologist, 16, 290-293.
15. HOURAN. J., & WILLIAMS, C. (1998). Relation of tolerance of ambiguity to global and specific paranormal experience. Psychological Reports, 83, 807-818.
16. KJELLGREN, A., & NORLANDER, T. (2000-2001). Psychedelic drugs: A study of drug-induced experiences obtained by illegal drug users in relation to Stanislav Grofs model of altered states of consciousness. Imagination, Cognition and Personality, 20, 41-57.
17. KOHR, R. L. (1980). A survey of psi experiences among members of a special population. Journal of the American Society for Psychical Research, 74, 395-411.
18. KUMAR, V. K., PEKALA., R. J., & GALLAGHER, C. (1994). The anomalous experiences inventory (AEI). Unpublished psychological test, West Chester University of Pennsylvania.
19. JANSEN, K. L. R. (1997). The ketamine model of the near death experience: A central role for the N-methyl-D-aspartate receptor. Journal of Near-Death Studies, 16, 5-26.
20. JANSEN, K. [L. R.] (2001). Ketamine: Dreams and realities. Sarasota, FL: Multidisciplinary Association for Psychedelic Studies.
21. LEARY, T., LITWIN, G. H., & METZNER, R. (1963). Reactions to psilocybin administered in a supportive environment. Journal of Nervous and Mental Disease, 137, 561-573.
22. LETCHER, A. (2004). Mad thoughts on mushrooms: Discourse and power in the study of psychedelic consciousness. [Audio CDROM]. Paper presented at the international conference Exploring Consciousness: With What Intent? Bath Spa University, UK.
23. LUKE, D. (2004a). Altered states of psi: A neurochemical perspective. [Audiocassette]. London: The Society for Psychical Research Invited Lecture Series.
24. LUKE, D. (2004b). Paranormal experiences and psychoactive drugs: A literature review project. Bulletin of the Multidisciplinary Association for Psychedelic Studies, 14, 11.
25. LUKE, D. (2004c). Psi-chedelics and science. Looking for the lost field of parapsychopharmacology. [Audio CDROM]. Paper presented at the international conference Exploring Consciousness: With What Intent? Bath Spa University, UK.
26. LUKE, D. (2005). Transpersonal and paranormal experiences with entheogenic substances: A parapsychological first-person perspective. Unpublished manuscript.
27. LUKE, D. (2006). A tribute to Albert Hofmann on his 100th birthday: The mysterious discovery of LSD and the impact of psychedelics on parapsychology. Paranormal Review, 37, 3-8.
28. LUKE, D. P. (in preparation). Psychoactive substances and paranormal phenomena. In S. Krippner (Ed.) Advances in parapsychology 9. New York: Parapsychology Foundation.
29. PALMER, J. (1979). A community mail survey of psychic experiences. Journal of the American Society for Psychical Research, 73, 221-251.
30. PEKALA, R. J., KUMAR, V. K., & MARCANO, G. (1995a). Anomalous/ paranormal experiences, hypnotic susceptibility, and dissociation. Journal of the American Society for Psychical Research, 89, 313-331.
31. PEKALA, R.J., KUMAR, V. K., & MARCANO, G. (1995b). Hypnotic susceptibility, dissociation, and marijuana use: A relationship between high hypnotic susceptibility, marijuana use, and dissociative ability. Paper presented at the annual meeting of the American Society of Clinical Hypnosis, San Diego, CA.
32. PRICE, L. H., & LEBEL, J. (2000). Dextromethorphan-induced psychosis. American Journal of Psychiatry, 157, 304.
33. RONEY-DOUGAL, S. M. (1991). Where science and magic meet. London: Element Books.
34. RONEY-DOUGAL, S. [M.] (2001). Walking between the worlds: Links between psi, psychedelics, shamanism, and psychosis. Unpublished manuscript, Psi Research Centre, Glastonbury, UK.
35. SAUNDERS, N. (1993). E for ecstasy. London: Nicholas Saunders.
36. SCHULTES, R. E., & HOFMANN, A. ( 1992). Plants of the Gods: Their sacred, healing, and hallucinogenic powers. Rochester, VT: Healing Arts Press.
37. SHANNON, B. (2003). Hallucinations. Journal of Consciousness Studies, 10, 3-31.
38. SHULGIN, A. T., & SHULGIN, A. ( 1991 ). PIHKAL: A chemical love story. Berkeley, CA: Transform Press.
39. SHULGIN, A. T., & SHULGIN, A. (1997). TIHKAL: The continuation. Berkeley, CA: Transform Press.
40. SIMMONDS, C. A., & ROE, C. A. (2000). Personality correlates of anomalous experiences, perceived ability and beliefs: Schizotypy, temporal lobe signs and gender. Proceedings of Presented Papers: The Parapsychological Association 43rd Annual Convention, 272-291.
41. SMITH, H. (2000). Cleansing the doors of perception: The religious significance of entheogenic plants and substances. New York: Jeremy P. Tarcher/ Putnum.
42. STOKES, D. M. (1997). Spontaneous psi phenomena. In S. Krippner (Ed.), Advances in parapsychological research 8 (pp. 6-87). Jefferson, NC: McFarland.
43. STRASSMAN, R. (2001). DMT: The spirit molecule: A doctor's revolutionary research into the biology of near-death and mystical experiences. Rochester, VT: Park Street Press.
44. TART, C. T. (1972). Considering the scientific study of the human aura. Journal of the Society for Psychical Research, 46, 1-21.
45. TART, C. T. (1993). Marijuana intoxication, psi, and spiritual experiences. The Journal of the American Society for Psychical Research, 87, 149-170.
46. THALBOURNE, M. A. (2001). Measures of the sheep goat variable, transliminality, and their correlates. Psychological Reports, 88, 339-350.
47. USHA, S., & PASRICHA, S. (1989a). Claims of paranormal experiences: I. Survey of psi and psi-related experiences. Journal of the National Institute of Mental Health and Neurosciences (India), 7, 143-150.
48. USHA, S., & PASRICHA, S. (1989b). Claims of paranormal experiences: II. Attitudes toward psychical research and factors associated with psi and psi-related experiences. Journal of the National Institute of Mental Health and Neurosciences (India), 7, 151-157.
49. VAYNE, J. (2001 ). Pharmakon: Drugs and the imagination. London: Liminalspace/ El Cheapo Books.
50. WHITE, W. E. (1997). Altered states and paranormal experiences. In W. E. White, The dextromethorphan FAQ: Answers to frequently asked questions about DXM (version 4). Retrieved April 2, 2002, from http://www. erowid.org/chemical/dxm/faq/dxm_paranormal.shtml.